A CLUSTER OF SARS-COV-2 DELTA VARIANT OF CONCERN ADDITIONALLY HARBORING F490S, NORTHERN LOMBARDY, ITALY.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 06 10 2021
revised: 29 11 2021
accepted: 23 12 2021
pubmed: 8 1 2022
medline: 3 3 2022
entrez: 7 1 2022
Statut: ppublish

Résumé

The Delta variant of concern (VOC) of SARS-CoV-2 has become dominant worldwide. In this article, we report a cluster caused by B.1.617.2 harboring the additional mutation of concern (MOC) F490S. We observed that 5 fully vaccinated subjects aged between 47 and 84 years were infected with this variant. The immune escape mutation F490S, first identified in the Lambda VOI, appears to impair vaccine efficacy and is rapidly increasing in prevalence worldwide.

Identifiants

pubmed: 34995777
pii: S1201-9712(21)01258-3
doi: 10.1016/j.ijid.2021.12.362
pmc: PMC8731264
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

271-272

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

Elife. 2020 Oct 28;9:
pubmed: 33112236
Science. 2021 Feb 12;371(6530):
pubmed: 33436526
Cell Host Microbe. 2021 Mar 10;29(3):477-488.e4
pubmed: 33535027
Open Forum Infect Dis. 2021 Jun 04;8(7):ofab295
pubmed: 34258320

Auteurs

Federica Novazzi (F)

Laboratory of Microbiology, ASST SetteLaghi, Varese, Italy.

Andreina Baj (A)

Laboratory of Microbiology, ASST SetteLaghi, Varese, Italy; Department of Medicine and Surgery, University of Insubria, Varese, Italy. Electronic address: andreina.baj@uninsubria.it.

Renee Pasciuta (R)

Laboratory of Microbiology, ASST SetteLaghi, Varese, Italy.

Angelo Genoni (A)

Department of Medicine and Surgery, University of Insubria, Varese, Italy.

Francesca Drago Ferrante (F)

Laboratory of Microbiology, ASST SetteLaghi, Varese, Italy.

Rosalia Tripiciano (R)

ATS Insubria, Varese, Italy.

Giuseppe Catanoso (G)

ATS Insubria, Varese, Italy.

Daniele Focosi (D)

North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.

Fabrizio Maggi (F)

Laboratory of Microbiology, ASST SetteLaghi, Varese, Italy; Department of Medicine and Surgery, University of Insubria, Varese, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH